Canntab Therapeutics Limited Stock Today
| CTABF Stock | USD 0.01 0.00 0.00% |
Performance9 of 100
| Odds Of DistressLess than 30
|
Canntab Therapeutics is trading at 0.0073 as of the 4th of May 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0073. Canntab Therapeutics has about a 30 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Canntab Therapeutics Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 15th of May 2022 and ending today, the 4th of May 2024. Click here to learn more.
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. Canntab Therapeutics Limited is headquartered in Markham, Canada. Canntab Therapeutics is traded on OTC Exchange in the United States.. The company has 38.91 M outstanding shares. More on Canntab Therapeutics Limited
Moving against Canntab Pink Sheet
| 0.58 | TAK | Takeda Pharmaceutical Earnings Call This Week | PairCorr |
| 0.56 | ESALY | Eisai Co | PairCorr |
| 0.56 | KEP | Korea Electric Power Earnings Call This Week | PairCorr |
| 0.49 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.44 | MKGAF | MERCK Kommanditgesells | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Canntab Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Canntab Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Canntab Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CoFounder, CEO | Richard Goldstein |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Canntab Therapeutics Limited [CTABF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 774.29 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Canntab Therapeutics's market, we take the total number of its shares issued and multiply it by Canntab Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Canntab Therapeutics classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 38.91 M outstanding shares.
Canntab Therapeutics Limited has accumulated about 691.11 K in cash with (2.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Canntab Therapeutics Probability Of Bankruptcy
Ownership AllocationCanntab Therapeutics holds a total of 38.91 Million outstanding shares. Canntab Therapeutics Limited shows 15.08 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Canntab Ownership Details
Canntab Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Canntab Therapeutics market risk premium is the additional return an investor will receive from holding Canntab Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Canntab Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Canntab Therapeutics' alpha and beta are two of the key measurements used to evaluate Canntab Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 19.62 | |||
| Standard Deviation | 59.36 | |||
| Variance | 3524.19 | |||
| Risk Adjusted Performance | 0.0879 |
Canntab Stock Against Markets
Picking the right benchmark for Canntab Therapeutics pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Canntab Therapeutics pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Canntab Therapeutics is critical whether you are bullish or bearish towards Canntab Therapeutics Limited at a given time. Please also check how Canntab Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Canntab Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
How to buy Canntab Pink Sheet?
Before investing in Canntab Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Canntab Therapeutics. To buy Canntab Therapeutics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Canntab Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Canntab Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Canntab Therapeutics Limited stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Canntab Therapeutics Limited stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Canntab Therapeutics Limited, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Canntab Therapeutics Limited?
The danger of trading Canntab Therapeutics Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Canntab Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Canntab Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Canntab Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Canntab Therapeutics Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Canntab Therapeutics information on this page should be used as a complementary analysis to other Canntab Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Canntab Pink Sheet analysis
When running Canntab Therapeutics' price analysis, check to measure Canntab Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Canntab Therapeutics is operating at the current time. Most of Canntab Therapeutics' value examination focuses on studying past and present price action to predict the probability of Canntab Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Canntab Therapeutics' price. Additionally, you may evaluate how the addition of Canntab Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |